References: 1. Bikowski J, Pillai R, Shroot B. The position not the presence of the halogen in corticosteroids influences potency and side effects. J Drugs Dermatol . 2006;5(2):125-130. 2. Del Rosso J, Friedlander SF. Corticosteroids: options in the era of steroid-sparing therapy. J Am Acad Dermatol . 2005; 53(1 Suppl 1):s50-s58. 3. US Food and Drug Administration NDA 017765. Promius Pharma, LLC, Princeton, NJ: Aug 1977. 4. Rosenthal AL. Clocortolone pivalate: a paired comparison clinical trial of a new topical steroid in eczema/atopic dermatitis. Cutis . 1980;25(1):96-98. 5. Kircik LH. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay. J Drugs Dermatol . 2014;13(5):582-585. 6. Cloderm [package insert]. Princeton, NJ: Promius Pharma, LLC; 2017.
If you believe you are ready for one of the following cycles you will have many cycles under your belt, supplemented with numerous anabolic steroids , 5 is a good number and have learned how to not only have successful cycles but ones in-which side-effects are controlled. Further, to be ready for an advanced cycle you will be one who is able to maintain more gains after a cycle than you lose. Some gains will always be lost after a cycle is complete, this is a given but maintaining a majority of your gains is possible. If this is not possible for you then you need to reexamine your use, your diet and perhaps even your training.